Full name
"MM-PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | -0,1 | -0,9 | -854,2 |
EBITDA | 0,7 | 0,2 | -0,7 | -522,3 |
Short time liabilities | 3,4 | 3,1 | 3 | -2,6 |
Equity capital | 3,8 | 3,8 | 2,9 | -21,7 |
Operating profit (EBIT) | 0,4 | -0,1 | -0,9 | -787,1 |
Assets | 7,6 | 7,1 | 6 | -15,2 |
Net profit (loss) | 0,5 | -0,1 | -0,8 | -958,2 |
Cash | 2 | 2,1 | 1,4 | -34,8 |
Net income from sale | 23,4 | 22,5 | 21 | -6,9 |
Liabilities and provisions for liabilities | 3,8 | 3,3 | 3,1 | -7,8 |
Working assets | 6,8 | 6,5 | 5,6 | -13,2 |
Depreciation | 0,2 | 0,3 | 0,2 | -38,9 |
% | % | % | p.p. | |
Profitability of capital | 11,8 | -2,1 | -27,8 | -25,7 |
Equity capital to total assets | 50,5 | 52,9 | 48,8 | -4,1 |
Gross profit margin | 2 | -0,4 | -4,3 | -3,9 |
EBITDA Margin | 2,8 | 0,8 | -3,5 | -4,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 53 | 50 | 53 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane